484 results on '"Hensley, Scott E."'
Search Results
2. Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus
3. COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network Study
4. Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
5. Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants
6. Landscape of coordinated immune responses to H1N1 challenge in humans
7. Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses
8. Deep mutational scanning of H5 hemagglutinin to inform influenza virus surveillance.
9. Preliminary Findings From the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: A Randomized Controlled Trial.
10. Deep mutational scanning of H5 hemagglutinin to inform influenza virus surveillance
11. Influenza virus antibodies inhibit antigen-specific de novo B cell responses in mice
12. Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia
13. Predictors of Nonseroconversion after SARS-CoV-2 Infection
14. Original antigenic sin priming of influenza virus hemagglutinin stalk antibodies
15. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
16. CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
17. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations
18. Neighborhood Characteristics and Racial Disparities in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seropositivity in Pregnancy
19. Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants
20. SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy
21. Measures of population immunity can predict the dominant clade of influenza A (H3N2) and reveal age-associated differences in susceptibility and specificity
22. Immunologic predictors of vaccine responsiveness in patients with lymphoma and CLL
23. Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012–2013
24. Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain
25. The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4+ T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway
26. Genomic Circuitry Underlying Immunological Response to Pediatric Acute Respiratory Infection
27. A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia
28. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
29. IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding
30. Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains
31. Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility
32. Antigenic assessment of the H3N2 component of the 2019-2020 Northern Hemisphere influenza vaccine
33. Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus
34. Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model
35. IGG3 Subclass Antibodies Recognize Antigenically Drifted Influenza Viruses and SARS-CoV-2 Variants Through Efficient Bivalent Binding
36. Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation
37. Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies
38. RNASEK is required for internalization of diverse acid-dependent viruses
39. A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
40. Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection
41. SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations
42. Assessment of SARS-CoV-2 serostatus and hypertensive disorders of pregnancy
43. IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding
44. COVID-19 and children
45. Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines
46. Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells
47. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season
48. Nucleoside-modified mRNA-based influenza vaccines circumvent problems associated with H3N2 vaccine strain egg-adaptation
49. Vaccination reshapes the virus-specific T cell repertoire in unexposed adults
50. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.